Jack Higgins, Chief Scientific Officer at Immunome Inc. (IMNM), sold 9,438 shares at $21.64 ($204K) on 2026-04-02, disclosed to the SEC on 2026-04-03.
Scheduled sale ($204k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |